Universe Pharmaceuticals ratios data for the quarter ended Mar 2026. These financial ratios cover 12 quarters of results from Sep 2020 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2020 | Mar2021 | Sep2021 | Mar2022 | Sep2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Efficiency | ||||||||||||
| Inventory AverageInventory Avg. | 0.00B | 0.00B | 0.00B | 1,103.25B | 1,103.25B | 1,671.63B | 3,364.66B | 2,561.55B | 2,651.50B | 2,879.57B | 2,086.49B | |
| Assets AverageAssets Avg. | 0.05B | 0.07B | 0.07B | 0.07B | 0.06B | 20,862.28B | 20,862.27B | 34.00B | 40,367.56B | 40,368.23B | 34.69B | |
| Invested CapitalInvested Cap. | 0.02B | 0.05B | 0.05B | 0.07B | 3,971.51B | 0.05B | 5,510.43B | 33,253.52B | 8,000.09B | 7,730.84B | 65,386.43B | 65,198.56B |
| Leverage & Solvency | ||||||||||||
| Debt Ratio | 0.09 | 0.04 | 0.06 | 0.06 | 0.00B | 0.06 | 0.13 | 0.00B | 117.73 | 0.10 | 133.57 | 0.00B |
| Valuation | ||||||||||||
| Price to BookP/B | 50.63 | 45.73 | 18.00 | 0.01 | 10.74 | 0.00 | 0.00 | 0.78 | 0.02 | 0.00 | 0.00 | |
| Enterprise Value | 2.53B | 2.13B | 1.09B | -5.23B | 0.48B | -185.79B | -2527.29B | -978.20B | -621.88B | -2523.33B | -1490.23B | |
| Market Capitalization | 2.57B | 2.15B | 1.10B | 0.49B | 0.51B | 0.14B | 0.32B | 0.04B | 0.00B | 0.00B | 0.00B |